<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2017.2882</article-id>
<article-id pub-id-type="publisher-id">ijmm-39-03-0603</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Morroniside protects SK-N-SH human neuroblastoma cells against H<sub>2</sub>O<sub>2</sub>-induced damage</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Jing-Xing</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Rui</given-names></name><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Xi</surname><given-names>Jin</given-names></name><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Shen</surname><given-names>Lin</given-names></name><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname><given-names>An-You</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Qi</surname><given-names>Qi</given-names></name><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Qi-Yi</given-names></name><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Lun-Jun</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Feng-Chao</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>L&#x000FC;</surname><given-names>He-Zuo</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-ijmm-39-03-0603"/></contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname><given-names>Jian-Guo</given-names></name><xref rid="af1-ijmm-39-03-0603" ref-type="aff">1</xref><xref rid="af2-ijmm-39-03-0603" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-ijmm-39-03-0603"/></contrib></contrib-group>
<aff id="af1-ijmm-39-03-0603">
<label>1</label>Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College</aff>
<aff id="af2-ijmm-39-03-0603">
<label>2</label>Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China</aff>
<author-notes>
<corresp id="c1-ijmm-39-03-0603">Correspondence to: Professor Jian-Guo Hu or Professor He-Zuo L&#x000FC;, Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, 287 Chang Huai Road, Bengbu, Anhui 233004, P.R. China, E-mail: <email>jghu9200@163.com</email>, E-mail: <email>lhz233003@163.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>03</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>02</month>
<year>2017</year></pub-date>
<volume>39</volume>
<issue>3</issue>
<fpage>603</fpage>
<lpage>612</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>09</month>
<year>2016</year></date>
<date date-type="accepted">
<day>31</day>
<month>01</month>
<year>2017</year></date></history>
<permissions>
<copyright-statement>Copyright: &#x000A9; Zhang et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions>
<abstract>
<p>Oxidative stress-induced cell injury has been linked to the pathogenesis of neurodegenerative disorders such as spinal cord injury, Parkinson's disease, and multiple sclerosis. Morroniside is an antioxidant derived from the Chinese herb Shan-Zhu-Yu. The present study investigated the neuroprotective effect of morroniside against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced cell death in SK-N-SH human neuroblastoma cells. H<sub>2</sub>O<sub>2</sub> increased cell apoptosis, as determined by flow cytometry and Hoechst 33342 staining. This effect was reversed by pretreatment with morroniside at concentrations of 1&#x02013;100 <italic>&#x000B5;</italic>M. The increase in intracellular reactive oxygen species (ROS) generation and lipid peroxidation induced by H<sub>2</sub>O<sub>2</sub> was also abrogated by morroniside. H<sub>2</sub>O<sub>2</sub> induced a reduction in mitochondrial membrane potential, increased caspase-3 activity, and caused downregulation of B cell lymphoma-2 (Bcl-2) and upregulation of Bcl-2-associated X protein (Bax) expression. These effects were blocked by morroniside pretreatment. Thus, morroniside protects human neuroblastoma cells against oxidative damage by inhibiting ROS production while suppressing Bax and stimulating Bcl-2 expression, thereby blocking mitochondrial-mediated apoptosis. These results indicate that morroniside has therapeutic potential for the prevention and treatment of neurodegenerative diseases.</p></abstract>
<kwd-group>
<kwd>morroniside</kwd>
<kwd>SK-N-SH cells</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>apoptosis</kwd>
<kwd>neuroprotection</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Neurodegenerative disorders are characterized by loss or dysfunction of neurons in the central nervous system (<xref rid="b1-ijmm-39-03-0603" ref-type="bibr">1</xref>,<xref rid="b2-ijmm-39-03-0603" ref-type="bibr">2</xref>). Oxidative stress and consequent mitochondrial dysfunction contribute to the pathology of spinal cord injury (<xref rid="b3-ijmm-39-03-0603" ref-type="bibr">3</xref>,<xref rid="b4-ijmm-39-03-0603" ref-type="bibr">4</xref>), stroke (<xref rid="b5-ijmm-39-03-0603" ref-type="bibr">5</xref>,<xref rid="b6-ijmm-39-03-0603" ref-type="bibr">6</xref>), Parkinson's disease (<xref rid="b7-ijmm-39-03-0603" ref-type="bibr">7</xref>), and Alzheimer's disease (<xref rid="b8-ijmm-39-03-0603" ref-type="bibr">8</xref>) via production of reactive oxygen species (ROS), which include hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), superoxide, singlet oxygen, and the hydroxyl radical (<xref rid="b9-ijmm-39-03-0603" ref-type="bibr">9</xref>).</p>
<p>ROS play an important role in intracellular signal transduction and gene expression in cell survival and organism development (<xref rid="b10-ijmm-39-03-0603" ref-type="bibr">10</xref>). However, excess accumulation of ROS can damage proteins, DNA and cell membranes (<xref rid="b11-ijmm-39-03-0603" ref-type="bibr">11</xref>). ROS induce cell death via the mitochondrial apoptosis pathway (<xref rid="b12-ijmm-39-03-0603" ref-type="bibr">12</xref>). Neurons are thought to be more susceptible to ROS owing to increased oxidative metabolism and fewer antioxidative enzymes (<xref rid="b13-ijmm-39-03-0603" ref-type="bibr">13</xref>,<xref rid="b14-ijmm-39-03-0603" ref-type="bibr">14</xref>). Suppression of ROS generation and inhibition of apoptosis can therefore potentially prevent neurodegeneration.</p>
<p><italic>Cornus officinalis</italic> is among the most commonly used Chinese medical herbs and has been used to treat kidney- and brain-related diseases (<xref rid="b15-ijmm-39-03-0603" ref-type="bibr">15</xref>). Its biological activities include antioxidant (<xref rid="b16-ijmm-39-03-0603" ref-type="bibr">16</xref>,<xref rid="b17-ijmm-39-03-0603" ref-type="bibr">17</xref>), anti-inflammatory (<xref rid="b18-ijmm-39-03-0603" ref-type="bibr">18</xref>) and antimicrobial (<xref rid="b19-ijmm-39-03-0603" ref-type="bibr">19</xref>) effects. Morroniside is the major active ingredient of <italic>C. officinalis</italic> extract (<xref rid="b20-ijmm-39-03-0603" ref-type="bibr">20</xref>) (<xref rid="f1-ijmm-39-03-0603" ref-type="fig">Fig. 1</xref>) and has been shown to reduce blood glucose, mitigate cerebral ischemia-reperfusion injury, and modulate the immune response (<xref rid="b21-ijmm-39-03-0603" ref-type="bibr">21</xref>). However, little is known concerning the effects of morroniside on oxidative stress-induced cell damage.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Cell culture and treatment</title>
<p>SK-N-SH human neuroblastoma cells (Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin/streptomycin (all from Invitrogen, Carlsbad, CA, USA) in plastic 25-cm<sup>2</sup> flasks at 37&#x000B0;C and under 5% CO<sub>2</sub>, 95% air. Culture medium was changed every other day and the cells were subcultured once attaining 70&#x02013;80% confluency. Morroniside (Phytomarker Ltd., Tianjin, China) was dissolved in D-PBS (Invitrogen) and H<sub>2</sub>O<sub>2</sub> (Sinopharm Chemical Reagent Co. Ltd., Shanghai, China) was dissolved in sterile distilled water. SK-N-SH cells were pretreated with different concentrations of morroniside for 24 h, followed by incubation with H<sub>2</sub>O<sub>2</sub> (200&#x02013;400 <italic>&#x000B5;</italic>M) for 24 h to induce injury.</p></sec>
<sec>
<title>Cell viability assay</title>
<p>The viability of the cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, SK-N-SH cells were plated into 96-well plates at the density of 5&#x000D7;10<sup>3</sup> cells/well. Cells were preincubated with morroniside (1, 10 and 100 <italic>&#x000B5;</italic>M) for 24 h before 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> was administered. After a 24-h incubation, 20 <italic>&#x000B5;</italic>l of a 5 mg/ml stock solution of MTT (Sigma, St. Louis, MO, USA) was added to the culture medium and incubated in the dark for 4 h at 37&#x000B0;C to allow for formazan formation. Then MTT formazan crystals were dissolved in 100 <italic>&#x000B5;</italic>l dimethyl sulfoxide (DMSO; Sigma) and spectrophotometrically determined at an absorbance of 570 nm. The percentage of cell viability was measured by normalization of all values to the control group (=100%).</p></sec>
<sec>
<title>Morphological observation</title>
<p>SK-N-SH cells were seeded into 6-well plates at the density of 2&#x000D7;10<sup>5</sup> cells/well. When cell confluency achieved 70&#x02013;80%, the cells were pre-incubated with morroniside for 24 h before H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) was added to induce cell damage for another 24 h. The growth and morphological changes in each group were observed under an inverted phase contrast microscope.</p></sec>
<sec>
<title>Cytotoxicity assay</title>
<p>Lactate dehydrogenase (LDH) assay was used to assay H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity. SK-N-SH cells were seed into 96-well plates at a density of 5&#x000D7;10<sup>3</sup> cells/well. After cells were exposed to H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) for 24 h, a total of 120 <italic>&#x000B5;</italic>l of cell medium was collected for LDH analysis according to the manufacturer's protocol included in the cytotoxicity assay kit (Beyotime Biotechnology, Nantong, China). The absorbance of each group was read at 490 nm. Each group had five duplicate wells and the experiments were repeated at least three times. Data are expressed as the percentage of LDH release of the injury group (H<sub>2</sub>O<sub>2</sub>-induced group).</p></sec>
<sec>
<title>Apoptosis analysis</title>
<p>In order to determine whether morroniside protects against H<sub>2</sub>O<sub>2</sub>-induced apoptosis, Hoechst 33342 (Sigma), a fluorescent nuclear dye, was used to detect cell apoptosis by observing the cell morphology. Briefly, SK-N-SH cells were treated as described above and then washed with phosphate-buffered saline (PBS) and incubated with Hoechst 33342 (10 <italic>&#x000B5;</italic>g/ml in PBS; Sigma) for 15 min at 37&#x000B0;C in the dark. The cells were washed with PBS, fixed with cold 4% paraformaldehyde for another 15 min in room temperature, washed with PBS again, and then examined by fluroescence microscopy. The percentage of apoptotic cells was calculated as the ratio of apoptotic cells to the total cells counted. At least 500 cells were counted from more than 3 random microscopic fields.</p>
<p>Moreover, in order to confirm the anti-apoptotic effect of morroniside, flow cytometry with Annexin V-FITC and propidium iodide (PI) double staining (Beyotime Biotechnology) was performed. After SK-N-SH cells were treated with H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M), 5&#x000D7;10<sup>5</sup> cells were collected and counted for Annexin V-FITC and PI double staining. Briefly, cells in different groups were washed three times with cold PBS and stained with Annexin V-FITC for 15 min in the dark. After cells were washed another three times, PI was added and the fluorescence of each group was immediately analyzed by flow cytometry.</p></sec>
<sec>
<title>Assessment of intracellular ROS production</title>
<p>For visualization and analysis of intracellular ROS, the oxidation sensitive probe DCFH-DA (Beyotime Biotechnology) was used. After the treatment of H<sub>2</sub>O<sub>2</sub>, SK-N-SH cells were exposed to 10 <italic>&#x000B5;</italic>M DCFH-DA for 20 min at 37&#x000B0;C in the dark. The cells were washed with PBS for 3 times, and then DCF fluorescence was observed using fluorescence microscopy and quantified by fluorescence multi-well plate reader (BioTek, Highland Park, VT, USA) with an excitation wavelength of 488 nm and emission wavelength of 525 nm.</p></sec>
<sec>
<title>Measurement of intracellular superoxide anion production</title>
<p>Superoxide anion was detected with dihydroethidium probes. Cells were treated with 2 <italic>&#x000B5;</italic>M dihydroethidium (Beyotime Biotechnology) for 30 min at 37&#x000B0;C in dim light after incubation with H<sub>2</sub>O<sub>2</sub>. Each well was washed with cold PBS and then DMEM to remove the remaining probes. Then cells were observed using fluorescence microscopy and the fluorescence intensity was quantified by a fluorescence multi-well plate reader.</p></sec>
<sec>
<title>Lipid peroxidation assay</title>
<p>Lipid peroxidation was monitored by measuring malondiadehyde (MDA; Beyotime Biotechnology), a stable end product of lipid peroxidation cascades using an MDA assay kit. SK-N-SH cells were washed with ice-cold PBS and then harvested with RIPA lysis buffer (Beyotime Biotechnology) after the treatment of H<sub>2</sub>O<sub>2</sub>. Cell homogenates were centrifuged at 16,000 &#x000D7; g at 4&#x000B0;C for 10 min. The supernatant was used for MDA assay and protein determination. The total protein concentrations were measured using BCA Protein assay kit (Beyotime Biotechnology). For MDA measurement, 100 <italic>&#x000B5;</italic>l samples were added into a 15-ml tube followed by addition of 200 <italic>&#x000B5;</italic>l MDA working solution. The mixture was heated at 100&#x000B0;C for 15 min, chilled to room temperature, and centrifuged at 1,000 &#x000D7; g for 10 min. Supernatants of 200 <italic>&#x000B5;</italic>l were transferred to 96-well plates, and the absorbance of each group was read at 532 nm.</p></sec>
<sec>
<title>Determination of activity of superoxide dismutase (SOD)</title>
<p>Cellular SOD levels were determined using a Superoxide Dismutase assay kit (Jiancheng Bioengineering Institute, Nanjing, China). SK-N-SH cells were pretreated with different concentrations of morroniside for 24 h prior to exposure to H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) for another 24 h. Cells were washed twice with ice-cold PBS and harvested in RIPA lysis buffer, and then total protein contents were determined with the BCA protein assay kit (Beyotime Biotechnology). Samples were collected and analyzed according to the manufacturer's instructions. SOD levels were normalized to the protein concentrations.</p></sec>
<sec>
<title>Monitoring mitochondrial membrane potential (MMP)</title>
<p>SK-N-SH cells were treated with various dose of morroniside in a 12-well plate for 24 h before H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) for 24 h. A fluorescent dye JC-1 (Beyotime Biotechnology) was added to achieve final concentration of 10 <italic>&#x000B5;</italic>g/ml. Then cells were incubated for 30 min at 37&#x000B0;C in dim light. Cells were washed with PBS to remove the excess dye, and then images were captured using fluorescence microscopy within 30 min. For the JC-1 monomer, excitation wavelength was 514 nm and maximum emission wavelength was 529 nm. For the JC-1 polymer, the maximum excitation and emission wavelength were 585 and 590 nm, respectively.</p></sec>
<sec>
<title>Measurement of caspase-3 activity</title>
<p>Activity of caspase-3 was measured with a commercial caspase-3 activity assay kit (Beyotime Biotechnology), using Ac-DEVD-pNA as the specific substrate. The cell pellets were lysed on ice in lysis buffer for 15 min, and then the lysate was centrifuged at 20,000 &#x000D7; g for 10 min at 4&#x000B0;C. Supernatant of 10 <italic>&#x000B5;</italic>l was collected and incubated with 10 <italic>&#x000B5;</italic>l Ac-DEVD-pNA (2 mM) at 37&#x000B0;C for another 1&#x02013;2 h in the dark. The absorbance values were measured with a spectrofluorometer at 405 nm and were corrected as protein content in the lysate. Protein concentration was determined by Bradford protein assay kit (Beyotime Biotechnology) according to the manufacturer's instructions.</p></sec>
<sec>
<title>Reverse transcription-polymerase chain reaction (RT-PCR)</title>
<p>The mRNA expression levels of B cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) were determined by RT-PCR. Briefly, SK-N-SH cells were treated as mentioned above, and the total RNA of each group was extracted using TRIzol agent (Invitrogen) according to the manufacturer's instructions. Two micrograms of total RNA was first reverse transcribed into cDNA, and then routine PCR was performed as previously described (<xref rid="b22-ijmm-39-03-0603" ref-type="bibr">22</xref>). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control and products were analyzed on 1% agarose gel. ImageJ software (NIH, Bethesda, MD, USA) was used to quantify the optical density value of each band. The sequences of specific primers (Sangon Biotech Inc., Shanghai, China) used for RT-PCR are listed in <xref rid="tI-ijmm-39-03-0603" ref-type="table">Table I</xref>.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Cells were collected at 24 h after exposure to H<sub>2</sub>O<sub>2</sub>. In order to detect the expression of Bcl-2 and Bax, SK-N-SH cells were washed with PBS and lysed using a lysis buffer for 30 min on ice. Lysates were centrifuged at 16,000 &#x000D7; g for 10 min at 4&#x000B0;C, and the supernatant was saved for the total protein determination. Protein concentrations were determined using a commercially available BCA protein assay kit (Beyotime Biotechnology). For western blot analysis, equivalent amounts of protein of each sample (20 <italic>&#x000B5;</italic>g) were electrophoresed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). After the membranes were blocked with 5% non-fat dry milk in Tris-buffered saline (TBS) for 1 h at room temperature, primary antibodies (in TBST-5% BSA) against Bcl-2 (1:2,000; 12789-1-AP) and Bax (1:5,000; 60267-1-Ig) (both from ProteinTech Group Inc, Chicago, IL, USA) were added and incubated overnight at 4&#x000B0;C for determining signal transduction events. The membranes were rinsed three times with TBST and incubated with an appropriate HRP-conjugated secondary antibody (1:2,000; #04-15-06 and #04-18-06) (both from KPL, Gaithersburg, MD, USA) for 1 h at 37&#x000B0;C. An ECL kit (Millipore) was used to visualize membrane immunoreactivity. Quantification was performed using a computerized imaging program Quantity One (Bio-Rad, Hercules, CA, USA).</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All data are presented as mean &#x000B1; standard deviation of the mean (SD). Statistical analyses were performed by one-way analysis of variance (ANOVA) with post hoc Tukey's t-test to determine statistical significance. A value of P&lt;0.05 was considered to indicated statistically significant differences.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Morroniside attenuates H<sub>2</sub>O<sub>2</sub>-induced cell death</title>
<p>H<sub>2</sub>O<sub>2</sub>-induced cell injury was evaluated using the MTT assay. H<sub>2</sub>O<sub>2</sub> reduced cell viability in a dose- and time-dependent manner, with a survival rate of 50% after 24 h in the presence of 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> relative to the untreated controls (<xref rid="f2-ijmm-39-03-0603" ref-type="fig">Fig. 2A</xref>). Cells were treated with various concentrations of morroniside for 24 h to determine whether the H<sub>2</sub>O<sub>2</sub>-induced decrease in viability would be mitigated. Morroniside had no effect on the survival of SK-N-SH cells that were not treated with H<sub>2</sub>O<sub>2</sub> (<xref rid="f2-ijmm-39-03-0603" ref-type="fig">Fig. 2B</xref>). However, pretreatment with morroniside attenuated the H<sub>2</sub>O<sub>2</sub>-induced decrease in cell survival in a dose-dependent manner, with the greatest effect observed at 10 <italic>&#x000B5;</italic>M (<xref rid="f2-ijmm-39-03-0603" ref-type="fig">Fig. 2C</xref>).</p></sec>
<sec>
<title>Morroniside reverses H<sub>2</sub>O<sub>2</sub>-induced morphological changes</title>
<p>SK-N-SH cells treated for 24 h with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> showed morphological changes including loss of cell projections; a round, swollen, or shrunken cell body; and aggregation. These changes were blocked by pretreatment with morroniside (<xref rid="f2-ijmm-39-03-0603" ref-type="fig">Fig. 2D</xref>).</p></sec>
<sec>
<title>Morroniside inhibits H<sub>2</sub>O<sub>2</sub>-induced LDH release</title>
<p>The LDH release assay showed that H<sub>2</sub>O<sub>2</sub> increased LDH activity in the supernatant of the SK-N-SH cell cultures relative to the control group. This effect was suppressed upon treatment with 1, 10 and 100 <italic>&#x000B5;</italic>M morroniside (P&lt;0.05) (<xref rid="f2-ijmm-39-03-0603" ref-type="fig">Fig. 2E</xref>).</p></sec>
<sec>
<title>Morroniside protects SK-N-SH cells from H<sub>2</sub>O<sub>2</sub>-induced apoptosis</title>
<p>We investigated whether the H<sub>2</sub>O<sub>2</sub>-induced decrease in SK-N-SH cell survival was due to apoptosis by Hoechst 33342 and Annexin V/PI staining. Control cells stained with Hoechst 33342 had large, oval-shaped nuclei (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3A</xref>). H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) treatment increased the fraction of cells with condensed or fragmented nuclei (18.60&#x000B1;1.67 vs. 2.00&#x000B1;1.00%; P&lt;0.01) (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3B and F</xref>). These defects were rescued by pretreatment with morroniside (1, 10 and 100 <italic>&#x000B5;</italic>M), which reduced the fraction of apoptotic cells (14.80&#x000B1;0.84, 10.40&#x000B1;1.14 and 13.20&#x000B1;1.48%, respectively vs. 18.60&#x000B1;1.67%; P&lt;0.01) (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3C&#x02013;F</xref>). Consistent with these findings, there were few cells positive for Annexin V/PI staining detected in the control group (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3G</xref>). H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) treatment increased the percentage of Annexin V<sup>+</sup>/PI<sup>+</sup> cells (34.58&#x000B1;4.59 vs. 4.96&#x000B1;2.44%; P&lt;0.001) (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3H and L</xref>), which was reduced by morroniside (1, 10 and 100 <italic>&#x000B5;</italic>M) treatment (26.86&#x000B1;4.05, 22.42&#x000B1;2.81 and 22.62&#x000B1;2.48%, respectively vs. 34.58&#x000B1;4.59%; P&lt;0.05) (<xref rid="f3-ijmm-39-03-0603" ref-type="fig">Fig. 3I&#x02013;L</xref>).</p></sec>
<sec>
<title>Morroniside inhibits H<sub>2</sub>O<sub>2</sub>-induced elevation in intracellular ROS level</title>
<p>Intracellular ROS levels were detected with 2,7&#x02032;-dichlorofluorescein (DCF) diacetate. SK-N-SH cells exposed to 200 and 400 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h showed dose-dependent increases in intracellular DCF fluorescence (P&lt;0.01) (<xref rid="f4-ijmm-39-03-0603" ref-type="fig">Fig. 4A&#x02013;C and G</xref>), indicating that ROS levels were elevated. However, 10 <italic>&#x000B5;</italic>M morroniside pretreatment abrogated these increases in fluorescence intensity compared to the H<sub>2</sub>O<sub>2</sub>-treated groups (P&lt;0.01) (<xref rid="f4-ijmm-39-03-0603" ref-type="fig">Fig. 4E&#x02013;G</xref>), suggesting a protective effect against H<sub>2</sub>O<sub>2</sub>-induced free radical formation.</p>
<p>Superoxide anion is a type of ROS that is associated with oxidative stress. To determine whether it is involved in H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity, we measured intracellular superoxide anion levels with the dihydroethidium probe (<xref rid="f4-ijmm-39-03-0603" ref-type="fig">Fig. 4H&#x02013;M</xref>). The fluorescence intensity of SK-N-SH cells increased markedly after incubation for 24 h with H<sub>2</sub>O<sub>2</sub> (P&lt;0.001) (<xref rid="f4-ijmm-39-03-0603" ref-type="fig">Fig. 4I and M</xref>). However, pretreatment with 1, 10 and 100 <italic>&#x000B5;</italic>M morroniside significantly reduced intracellular superoxide anion levels.</p></sec>
<sec>
<title>Morroniside suppresses H<sub>2</sub>O<sub>2</sub>-induced lipid peroxidation</title>
<p>Lipid peroxidation levels were monitored by detecting the stable end products of lipid peroxidation using an MDA assay kit. Under normal conditions, cellular MDA content was ~119.47&#x000B1;14.14 nmol/g protein (<xref rid="f5-ijmm-39-03-0603" ref-type="fig">Fig. 5</xref>). In cells treated with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h, the level was increased to 296.28&#x000B1;24.25 nmol/g protein (P&lt;0.001). However, pretreatment with 1, 10 and 100 <italic>&#x000B5;</italic>M morroniside reduced MDA levels to 256.26&#x000B1;6.70, 223.63&#x000B1;12.47 and 224.35&#x000B1;10.18 nmol/g protein, respectively (P&lt;0.05).</p></sec>
<sec>
<title>Morroniside inhibits H<sub>2</sub>O<sub>2</sub>-induced SOD depletion</title>
<p>To investigate the antioxidant properties of morroniside, we measured intracellular levels of SOD. Treatment with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h reduced intracellular SOD levels from 6.77&#x000B1;0.45 to 3.74&#x000B1;0.41 U/mg (P&lt;0.001). This was reversed by morroniside pretreatment at concentrations ranging from 1 to 100 <italic>&#x000B5;</italic>M; for example, a concentration of 10 <italic>&#x000B5;</italic>M enhanced SOD level by over 45% relative to the H<sub>2</sub>O<sub>2</sub>-treated group (<xref rid="f6-ijmm-39-03-0603" ref-type="fig">Fig. 6</xref>).</p></sec>
<sec>
<title>Morroniside suppresses H<sub>2</sub>O<sub>2</sub>-induced decreases in MMP</title>
<p>We investigated whether morroniside could suppress the H<sub>2</sub>O<sub>2</sub>-induced decrease in MMP using JC-1 dye. SK-N-SH cells treated with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h showed an obvious decrease in MMP, as evidenced by a decrease in the ratio of red to green fluorescence (<xref rid="f7-ijmm-39-03-0603" ref-type="fig">Fig. 7</xref>). This effect was mitigated by treatment with morroniside, most obviously at a concentration of 10 <italic>&#x000B5;</italic>M.</p></sec>
<sec>
<title>Morroniside inhibits H<sub>2</sub>O<sub>2</sub>-induced caspase-3 level</title>
<p>Caspase-3 is a key protein in the regulation of apoptosis. SK-N-SH cells treated with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h showed a nearly 2-fold increase in the caspase-3 level relative to the control cells (P&lt;0.01) (<xref rid="f8-ijmm-39-03-0603" ref-type="fig">Fig. 8</xref>). Pretreatment with morroniside (1, 10 and 100 <italic>&#x000B5;</italic>M) suppressed the H<sub>2</sub>O<sub>2</sub>-induced upregulation of caspase-3 (3.77&#x000B1;0.31, 3.05&#x000B1;0.16 and 3.31&#x000B1;0.12 <italic>&#x000B5;</italic>M pNA/g, respectively vs. 4.91&#x000B1;0.36 <italic>&#x000B5;</italic>M pNA/g; P&lt;0.05).</p></sec>
<sec>
<title>Morroniside modulates expression of apoptosis-related proteins</title>
<p>The expression levels of the apoptosis-related genes Bcl-2 and Bax were altered in the SK-N-SH cells by H<sub>2</sub>O<sub>2</sub> administration; the Bcl-2 mRNA level was downregulated while that of Bax was upregulated (<xref rid="f9-ijmm-39-03-0603" ref-type="fig">Fig. 9A&#x02013;C</xref>). These changes were abolished by pretreatment with 1&#x02013;100 <italic>&#x000B5;</italic>M morroniside. Similarly, western blot analysis revealed that H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) decreased the Bcl-2 level (P&lt;0.001) and increased that of Bax (P&lt;0.01) after 24 h (<xref rid="f9-ijmm-39-03-0603" ref-type="fig">Fig. 9D&#x02013;F</xref>). However, pretreatment with 1, 10 and 100 <italic>&#x000B5;</italic>M morroniside restored Bcl-2 and Bax expression levels compared to these levels in the H<sub>2</sub>O<sub>2</sub>-induced group.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Oxidative stress caused by ROS is implicated in the pathogenesis of most chronic diseases (<xref rid="b23-ijmm-39-03-0603" ref-type="bibr">23</xref>,<xref rid="b24-ijmm-39-03-0603" ref-type="bibr">24</xref>). ROS accumulation results in cellular damage (<xref rid="b5-ijmm-39-03-0603" ref-type="bibr">5</xref>). Loss of neurons due to oxidative stress plays a key role in the development of cerebrovascular and/or neurodegenerative diseases (<xref rid="b1-ijmm-39-03-0603" ref-type="bibr">1</xref>,<xref rid="b8-ijmm-39-03-0603" ref-type="bibr">8</xref>,<xref rid="b25-ijmm-39-03-0603" ref-type="bibr">25</xref>). Neurons are thought to be more susceptible to oxidative damage than other cell types due to their high oxygen consumption and low antioxidant capabilities (<xref rid="b26-ijmm-39-03-0603" ref-type="bibr">26</xref>). In the present study, we found that H<sub>2</sub>O<sub>2</sub>, a freely diffusible ROS, induced apoptosis in the human neuroblastoma SK-N-SH cells.</p>
<p>Usually, antioxidants, especially those derived from natural sources, have many therapeutic applications (<xref rid="b27-ijmm-39-03-0603" ref-type="bibr">27</xref>,<xref rid="b28-ijmm-39-03-0603" ref-type="bibr">28</xref>). Morroniside is a constituent of <italic>C. officinalis</italic>, a traditional Chinese medicine (<xref rid="b29-ijmm-39-03-0603" ref-type="bibr">29</xref>), and has demonstrated protective effects against cerebral ischemic damage (<xref rid="b15-ijmm-39-03-0603" ref-type="bibr">15</xref>), indicating a potential role of morroniside on restoring injured neurons. However, little is known concerning the underlying mechanisms. In this study, we investigated the neuroprotective role of morroniside in SK-N-SH cells treated with H<sub>2</sub>O<sub>2</sub>.</p>
<p>Exposure of cells to exogenous H<sub>2</sub>O<sub>2</sub> can induce ROS overproduction (<xref rid="b30-ijmm-39-03-0603" ref-type="bibr">30</xref>), leading to peroxidation of membrane lipids and disruption of cellular integrity (<xref rid="b31-ijmm-39-03-0603" ref-type="bibr">31</xref>). The present study showed that pretreatment with morroniside reversed H<sub>2</sub>O<sub>2</sub>-induced apoptosis by blocking ROS production.</p>
<p>SOD is a component of the antioxidant machinery in neurons (<xref rid="b32-ijmm-39-03-0603" ref-type="bibr">32</xref>). In most situations, ROS produced through metabolic processes are quenched by intracellular defense systems, including SOD (<xref rid="b33-ijmm-39-03-0603" ref-type="bibr">33</xref>). Previous studies have shown that depletion of cellular glutathione leads to accumulation of ROS and mitochondrial dysfunction (<xref rid="b34-ijmm-39-03-0603" ref-type="bibr">34</xref>). We found here that morroniside treatment increased SOD activity in the SK-N-SH cells, which prevented ROS accumulation. Thus, we propose that the cytoprotective effects of morroniside are associated with its antioxidant capacity, for which, antioxidants such as glutathione or SOD are indispensable.</p>
<p>Overproduction of ROS disrupts the intracellular redox equilibrium, resulting in apoptosis (<xref rid="b35-ijmm-39-03-0603" ref-type="bibr">35</xref>). ROS target mitochondrial membrane proteins, leading to activation of the mitochondrial permeability transition pore, which decreases the MMP (<xref rid="b36-ijmm-39-03-0603" ref-type="bibr">36</xref>) and releases cytochrome <italic>c</italic> into the cytosol, where it binds to apoptotic protease activating factor 1 and forms the apoptosome, which activates pro-apoptotic caspases (<xref rid="b37-ijmm-39-03-0603" ref-type="bibr">37</xref>). Indeed, we observed that H<sub>2</sub>O<sub>2</sub> treatment reduced the MMP and activated the pro-apoptotic protein caspase-3. These effects were blocked by pretreatment with morroniside, suggesting that morroniside exerts protective effects by blocking the mitochondrial apoptotic pathway.</p>
<p>H<sub>2</sub>O<sub>2</sub> has been reported to modulate the levels of Bcl-2 and Bax, two genes associated with mitochondrial apoptosis, in various cell types including cortical neurons (<xref rid="b30-ijmm-39-03-0603" ref-type="bibr">30</xref>), endothelial cells (<xref rid="b38-ijmm-39-03-0603" ref-type="bibr">38</xref>), and HT22 cells (<xref rid="b39-ijmm-39-03-0603" ref-type="bibr">39</xref>), specifically by suppressing Bcl-2 and stimulating Bax expression (<xref rid="b30-ijmm-39-03-0603" ref-type="bibr">30</xref>). This was observed in our study at both the mRNA and protein levels following administration of H<sub>2</sub>O<sub>2</sub> for 24 h. Moreover, morroniside treatment reversed the changes in Bcl-2 and Bax expression induced by H<sub>2</sub>O<sub>2</sub>. The pro-apoptotic protein Bax is activated during apoptosis, and its relocation from the cytoplasm to the mitochondrial outer membrane leads to formation of the mitochondrial permeability transition pore and downstream events. Bax accumulated in the mitochondrial outer membrane binds to the anti-apoptotic protein Bcl-2 and maintains it in an inactive state (<xref rid="b37-ijmm-39-03-0603" ref-type="bibr">37</xref>). Bcl-2 also acts as an antioxidant by suppressing ROS levels and the mitochondrial apoptosis pathway (<xref rid="b40-ijmm-39-03-0603" ref-type="bibr">40</xref>). Taken together, these findings suggest that morroniside blocks mitochondrial apoptosis via modulation of Bcl-2 and Bax expression.</p>
<p>In conclusion, in the present study, morroniside was found to protect against H<sub>2</sub>O<sub>2</sub>-induced oxidative damage in SK-N-SH neuronal cells. This effect was mediated by inhibition of ROS-induced oxidative stress as well as suppressing and stimulating Bax and Bcl-2 expression, respectively, leading to inhibition of the mitochondrial apoptotic pathway. Thus, morroniside can potentially be used for the prevention and treatment of neurodegenerative diseases.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The present study was supported by the National Natural Science Foundation of China (no. 81471277) and the Program of Anhui Province for Academic and Technical Leader in University.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-39-03-0603"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dest&#x000E9;e</surname><given-names>A</given-names></name><name><surname>Mutez</surname><given-names>E</given-names></name><name><surname>Kreisler</surname><given-names>A</given-names></name><name><surname>Vanbesien-Maillot</surname><given-names>C</given-names></name><name><surname>Chartier-Harlin</surname><given-names>MC</given-names></name></person-group><article-title>Parkinson disease: Genetics and neuronal death</article-title><source>Rev Neurol (Paris)</source><volume>165</volume><fpage>F80</fpage><lpage>F85</lpage><year>2009</year><comment>In French</comment></element-citation></ref>
<ref id="b2-ijmm-39-03-0603"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeineddine</surname><given-names>R</given-names></name><name><surname>Yerbury</surname><given-names>JJ</given-names></name></person-group><article-title>The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases</article-title><source>Front Physiol</source><volume>6</volume><fpage>277</fpage><year>2015</year><pub-id pub-id-type="doi">10.3389/fphys.2015.00277</pub-id><pub-id pub-id-type="pmid">26528186</pub-id><pub-id pub-id-type="pmcid">4607857</pub-id></element-citation></ref>
<ref id="b3-ijmm-39-03-0603"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Misra</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Oxidative stress in spinal cord injury and antioxidant-based intervention</article-title><source>Spinal Cord</source><volume>50</volume><fpage>264</fpage><lpage>274</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/sc.2011.111</pub-id></element-citation></ref>
<ref id="b4-ijmm-39-03-0603"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bains</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>ED</given-names></name></person-group><article-title>Antioxidant therapies in traumatic brain and spinal cord injury</article-title><source>Biochim Biophys Acta</source><volume>1822</volume><fpage>675</fpage><lpage>684</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bbadis.2011.10.017</pub-id></element-citation></ref>
<ref id="b5-ijmm-39-03-0603"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigo</surname><given-names>R</given-names></name><name><surname>Fern&#x000E1;ndez-Gajardo</surname><given-names>R</given-names></name><name><surname>Guti&#x000E9;rrez</surname><given-names>R</given-names></name><name><surname>Matamala</surname><given-names>JM</given-names></name><name><surname>Carrasco</surname><given-names>R</given-names></name><name><surname>Miranda-Merchak</surname><given-names>A</given-names></name><name><surname>Feuerhake</surname><given-names>W</given-names></name></person-group><article-title>Oxidative stress and pathophysiology of ischemic stroke: Novel therapeutic opportunities</article-title><source>CNS Neurol Disord Drug Targets</source><volume>12</volume><fpage>698</fpage><lpage>714</lpage><year>2013</year><pub-id pub-id-type="doi">10.2174/1871527311312050015</pub-id><pub-id pub-id-type="pmid">23469845</pub-id></element-citation></ref>
<ref id="b6-ijmm-39-03-0603"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirley</surname><given-names>R</given-names></name><name><surname>Ord</surname><given-names>EN</given-names></name><name><surname>Work</surname><given-names>LM</given-names></name></person-group><article-title>Oxidative stress and the use of antioxidants in stroke</article-title><source>Antioxidants Basel</source><volume>3</volume><fpage>472</fpage><lpage>501</lpage><year>2014</year><pub-id pub-id-type="doi">10.3390/antiox3030472</pub-id><pub-id pub-id-type="pmid">26785066</pub-id><pub-id pub-id-type="pmcid">4665418</pub-id></element-citation></ref>
<ref id="b7-ijmm-39-03-0603"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>V</given-names></name><name><surname>Junn</surname><given-names>E</given-names></name><name><surname>Mouradian</surname><given-names>MM</given-names></name></person-group><article-title>The role of oxidative stress in Parkinson's disease</article-title><source>J Parkinsons Dis</source><volume>3</volume><fpage>461</fpage><lpage>491</lpage><year>2013</year><pub-id pub-id-type="pmid">24252804</pub-id><pub-id pub-id-type="pmcid">4135313</pub-id></element-citation></ref>
<ref id="b8-ijmm-39-03-0603"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovell</surname><given-names>MA</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name></person-group><article-title>Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease</article-title><source>Nucleic Acids Res</source><volume>35</volume><fpage>7497</fpage><lpage>7504</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/nar/gkm821</pub-id><pub-id pub-id-type="pmid">17947327</pub-id><pub-id pub-id-type="pmcid">2190704</pub-id></element-citation></ref>
<ref id="b9-ijmm-39-03-0603"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khojah</surname><given-names>HM</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Abdel-Rahman</surname><given-names>MS</given-names></name><name><surname>Hamza</surname><given-names>AB</given-names></name></person-group><article-title>Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants</article-title><source>Free Radic Biol Med</source><volume>97</volume><fpage>285</fpage><lpage>291</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.06.020</pub-id><pub-id pub-id-type="pmid">27344969</pub-id></element-citation></ref>
<ref id="b10-ijmm-39-03-0603"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000F6;ge</surname><given-names>W</given-names></name></person-group><article-title>Free radicals in the physiological control of cell function</article-title><source>Physiol Rev</source><volume>82</volume><fpage>47</fpage><lpage>95</lpage><year>2002</year><pub-id pub-id-type="doi">10.1152/physrev.00018.2001</pub-id><pub-id pub-id-type="pmid">11773609</pub-id></element-citation></ref>
<ref id="b11-ijmm-39-03-0603"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrens</surname><given-names>JF</given-names></name></person-group><article-title>Mitochondrial formation of reactive oxygen species</article-title><source>J Physiol</source><volume>552</volume><fpage>335</fpage><lpage>344</lpage><year>2003</year><pub-id pub-id-type="doi">10.1113/jphysiol.2003.049478</pub-id><pub-id pub-id-type="pmid">14561818</pub-id><pub-id pub-id-type="pmcid">2343396</pub-id></element-citation></ref>
<ref id="b12-ijmm-39-03-0603"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HG</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name></person-group><article-title>PKC-&#x003B4; mediates TCDD-induced apoptosis of chondrocyte in ROS-dependent manner</article-title><source>Chemosphere</source><volume>81</volume><fpage>1039</fpage><lpage>1044</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.chemosphere.2010.08.045</pub-id><pub-id pub-id-type="pmid">20846705</pub-id></element-citation></ref>
<ref id="b13-ijmm-39-03-0603"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>K</given-names></name><name><surname>Durkes</surname><given-names>A</given-names></name><name><surname>Ouyang</surname><given-names>H</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Pond</surname><given-names>A</given-names></name><name><surname>Shi</surname><given-names>R</given-names></name></person-group><article-title>Critical role of acrolein in secondary injury following ex vivo spinal cord trauma</article-title><source>J Neurochem</source><volume>107</volume><fpage>712</fpage><lpage>721</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05622.x</pub-id><pub-id pub-id-type="pmid">18710419</pub-id><pub-id pub-id-type="pmcid">2671023</pub-id></element-citation></ref>
<ref id="b14-ijmm-39-03-0603"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>R</given-names></name></person-group><article-title>Acrolein scavenging: A potential novel mechanism of attenuating oxidative stress following spinal cord injury</article-title><source>J Neurochem</source><volume>111</volume><fpage>1348</fpage><lpage>1356</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06395.x</pub-id><pub-id pub-id-type="pmid">19780896</pub-id></element-citation></ref>
<ref id="b15-ijmm-39-03-0603"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huo</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Identification of new metabolites of morroniside produced by rat intestinal bacteria and HPLC-PDA analysis of metabolites in vivo</article-title><source>J Pharm Biomed Anal</source><volume>45</volume><fpage>268</fpage><lpage>274</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.jpba.2007.07.009</pub-id><pub-id pub-id-type="pmid">17707607</pub-id></element-citation></ref>
<ref id="b16-ijmm-39-03-0603"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Noh</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Shibahara</surname><given-names>N</given-names></name><name><surname>Yokozawa</surname><given-names>T</given-names></name></person-group><article-title>Evaluation of morroniside, iri glycoside from Corni Fructus, on diabetes-induced alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice</article-title><source>Biol Pharm Bull</source><volume>34</volume><fpage>1559</fpage><lpage>1565</lpage><year>2011</year><pub-id pub-id-type="doi">10.1248/bpb.34.1559</pub-id></element-citation></ref>
<ref id="b17-ijmm-39-03-0603"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>HX</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>FL</given-names></name><name><surname>Huang</surname><given-names>WT</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>Morroniside inhibits H<sub>2</sub>O<sub>2</sub> cells</article-title><source>Zhongguo Zhong Yao Za Zhi -induced apoptosis in cultured nerve</source><volume>33</volume><fpage>2109</fpage><lpage>2112</lpage><year>2008</year><comment>In Chinese</comment></element-citation></ref>
<ref id="b18-ijmm-39-03-0603"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>SE</given-names></name><name><surname>Jeong</surname><given-names>JJ</given-names></name><name><surname>Hyam</surname><given-names>SR</given-names></name><name><surname>Han</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name></person-group><article-title>Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages</article-title><source>J Agric Food Chem</source><volume>62</volume><fpage>9711</fpage><lpage>9721</lpage><year>2014</year><pub-id pub-id-type="doi">10.1021/jf501487v</pub-id><pub-id pub-id-type="pmid">25213465</pub-id></element-citation></ref>
<ref id="b19-ijmm-39-03-0603"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>HH</given-names></name><name><surname>Hur</surname><given-names>JM</given-names></name><name><surname>Seo</surname><given-names>SJ</given-names></name><name><surname>Moon</surname><given-names>HD</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>RK</given-names></name><name><surname>You</surname><given-names>YO</given-names></name></person-group><article-title>Protective effect of ursolic acid from Cornus officinalis on the hydrogen peroxide-induced damage of HEI-OC1 auditory cells</article-title><source>Am J Chin Med</source><volume>37</volume><fpage>735</fpage><lpage>746</lpage><year>2009</year><pub-id pub-id-type="doi">10.1142/S0192415X0900720X</pub-id><pub-id pub-id-type="pmid">19655411</pub-id></element-citation></ref>
<ref id="b20-ijmm-39-03-0603"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Ahn</surname><given-names>M-J</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Sung</surname><given-names>SH</given-names></name></person-group><article-title>Efficient method for extraction and simultaneous determination of active constituents in Cornus officinalis by reflux extraction and high performance liquid chromatography with diode array detection</article-title><source>J Liq Chromatogr Relat Technol</source><volume>32</volume><fpage>822</fpage><lpage>832</lpage><year>2009</year><pub-id pub-id-type="doi">10.1080/10826070902768021</pub-id></element-citation></ref>
<ref id="b21-ijmm-39-03-0603"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>CY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>YH</given-names></name><name><surname>Ai</surname><given-names>HX</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Effects of extract from Cornus officinalis on nitric oxide and NF-kappaB in cortex of cerebral infarction rat model</article-title><source>Zhongguo Zhong Yao Za Zhi</source><volume>30</volume><fpage>1667</fpage><lpage>1670</lpage><year>2005</year><comment>In Chinese</comment></element-citation></ref>
<ref id="b22-ijmm-39-03-0603"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>JG</given-names></name><name><surname>Fu</surname><given-names>SL</given-names></name><name><surname>Zhang</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>PH</given-names></name><name><surname>Xu</surname><given-names>XM</given-names></name></person-group><article-title>Differential gene expression in neural stem cells and oligodendrocyte precursor cells: a cDNA microarray analysis</article-title><source>J Neurosci Res</source><volume>78</volume><fpage>637</fpage><lpage>646</lpage><year>2004</year><pub-id pub-id-type="doi">10.1002/jnr.20317</pub-id><pub-id pub-id-type="pmid">15499592</pub-id></element-citation></ref>
<ref id="b23-ijmm-39-03-0603"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>V</given-names></name><name><surname>Deep</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Palle</surname><given-names>K</given-names></name><name><surname>Yadav</surname><given-names>UC</given-names></name><name><surname>Yadav</surname><given-names>UC</given-names></name></person-group><article-title>Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies</article-title><source>Life Sci</source><volume>148</volume><fpage>183</fpage><lpage>193</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.lfs.2016.02.002</pub-id><pub-id pub-id-type="pmid">26851532</pub-id></element-citation></ref>
<ref id="b24-ijmm-39-03-0603"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda-D&#x000ED;az</surname><given-names>AG</given-names></name><name><surname>Pazar&#x000ED;n-Villase&#x000F1;or</surname><given-names>L</given-names></name><name><surname>Yanowsky-Escatel</surname><given-names>FG</given-names></name><name><surname>Andrade-Sierra</surname><given-names>J</given-names></name></person-group><article-title>Oxidative stress in fiabetic nephropathy with early chronic kidney disease</article-title><source>J Diabetes Res</source><volume>2016</volume><fpage>7047238</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/7047238</pub-id></element-citation></ref>
<ref id="b25-ijmm-39-03-0603"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forte</surname><given-names>M</given-names></name><name><surname>Conti</surname><given-names>V</given-names></name><name><surname>Damato</surname><given-names>A</given-names></name><name><surname>Ambrosio</surname><given-names>M</given-names></name><name><surname>Puca</surname><given-names>AA</given-names></name><name><surname>Sciarretta</surname><given-names>S</given-names></name><name><surname>Frati</surname><given-names>G</given-names></name><name><surname>Vecchione</surname><given-names>C</given-names></name><name><surname>Carrizzo</surname><given-names>A</given-names></name></person-group><article-title>Targeting nitric oxide with natural derived compounds as a therapeutic strategy in vascular diseases</article-title><source>Oxid Med Cell Longev</source><volume>2016</volume><fpage>7364138</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/7364138</pub-id><pub-id pub-id-type="pmid">27651855</pub-id><pub-id pub-id-type="pmcid">5019908</pub-id></element-citation></ref>
<ref id="b26-ijmm-39-03-0603"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpinska</surname><given-names>A</given-names></name><name><surname>Gromadzka</surname><given-names>G</given-names></name></person-group><article-title>Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies</article-title><source>Postepy Higieny i Medycyny Doswiadczalnej (Online)</source><volume>67</volume><fpage>43</fpage><lpage>53</lpage><year>2013</year><pub-id pub-id-type="doi">10.5604/17322693.1029530</pub-id></element-citation></ref>
<ref id="b27-ijmm-39-03-0603"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turkez</surname><given-names>H</given-names></name><name><surname>Sozio</surname><given-names>P</given-names></name><name><surname>Geyikoglu</surname><given-names>F</given-names></name><name><surname>Tatar</surname><given-names>A</given-names></name><name><surname>Hacimuftuoglu</surname><given-names>A</given-names></name><name><surname>Di Stefano</surname><given-names>A</given-names></name></person-group><article-title>Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro</article-title><source>Cell Mol Neurobiol</source><volume>34</volume><fpage>101</fpage><lpage>111</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10571-013-9991-y</pub-id></element-citation></ref>
<ref id="b28-ijmm-39-03-0603"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>LL</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Sun</surname><given-names>YN</given-names></name><name><surname>Li</surname><given-names>CR</given-names></name><name><surname>Xing</surname><given-names>YL</given-names></name><name><surname>Zhao</surname><given-names>HB</given-names></name><name><surname>Duan</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>SQ</given-names></name></person-group><article-title>Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells</article-title><source>Int J Biochem Cell Biol</source><volume>40</volume><fpage>409</fpage><lpage>422</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.biocel.2007.08.005</pub-id></element-citation></ref>
<ref id="b29-ijmm-39-03-0603"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>MY</given-names></name><name><surname>Yu</surname><given-names>ZL</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Cai</surname><given-names>BC</given-names></name></person-group><article-title>Studies on separation, appraisal and the biological activity of 5-HMF in Cornus officinalis</article-title><source>Zhongguo Zhong Yao Za Zhi</source><volume>33</volume><fpage>392</fpage><lpage>396</lpage><fpage>484</fpage><year>2008</year><comment>In Chinese</comment></element-citation></ref>
<ref id="b30-ijmm-39-03-0603"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Nie</surname><given-names>B</given-names></name><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>XM</given-names></name></person-group><article-title>EGb 761 protects hydrogen peroxide-induced death of spinal cord neurons through inhibition of intracellular ROS production and modulation of apoptotic regulating genes</article-title><source>J Mol Neurosci</source><volume>38</volume><fpage>103</fpage><lpage>113</lpage><year>2009</year><pub-id pub-id-type="doi">10.1007/s12031-008-9140-0</pub-id><pub-id pub-id-type="pmid">19148782</pub-id></element-citation></ref>
<ref id="b31-ijmm-39-03-0603"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name></person-group><article-title>Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress</article-title><source>Can J Physiol Pharmacol</source><volume>84</volume><fpage>1267</fpage><lpage>1273</lpage><year>2006</year><pub-id pub-id-type="doi">10.1139/y06-075</pub-id></element-citation></ref>
<ref id="b32-ijmm-39-03-0603"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname><given-names>JB</given-names></name><name><surname>White</surname><given-names>AR</given-names></name><name><surname>Crouch</surname><given-names>PJ</given-names></name></person-group><article-title>Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS</article-title><source>Metallomics</source><volume>8</volume><fpage>1002</fpage><lpage>1011</lpage><year>2016</year><pub-id pub-id-type="doi">10.1039/C6MT00099A</pub-id><pub-id pub-id-type="pmid">27357743</pub-id></element-citation></ref>
<ref id="b33-ijmm-39-03-0603"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>KA</given-names></name><name><surname>Hwang</surname><given-names>YJ</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells</article-title><source>BMC Complement Altern Med</source><volume>16</volume><fpage>196</fpage><year>2016</year><pub-id pub-id-type="doi">10.1186/s12906-016-1172-3</pub-id><pub-id pub-id-type="pmid">27391600</pub-id><pub-id pub-id-type="pmcid">4939040</pub-id></element-citation></ref>
<ref id="b34-ijmm-39-03-0603"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharat</surname><given-names>S</given-names></name><name><surname>Cochran</surname><given-names>BC</given-names></name><name><surname>Hsu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name><name><surname>Andersen</surname><given-names>JK</given-names></name></person-group><article-title>Pretreatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: Implications for Parkinson's disease therapy</article-title><source>Neurotoxicology</source><volume>23</volume><fpage>479</fpage><lpage>486</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0161-813X(02)00035-9</pub-id><pub-id pub-id-type="pmid">12428720</pub-id></element-citation></ref>
<ref id="b35-ijmm-39-03-0603"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>JH</given-names></name><name><surname>Ivins</surname><given-names>KJ</given-names></name><name><surname>Van Houten</surname><given-names>B</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><article-title>Bcl-2 facilitates recovery from DNA damage after oxidative stress</article-title><source>Exp Neurol</source><volume>159</volume><fpage>309</fpage><lpage>318</lpage><year>1999</year><pub-id pub-id-type="doi">10.1006/exnr.1999.7145</pub-id><pub-id pub-id-type="pmid">10486199</pub-id></element-citation></ref>
<ref id="b36-ijmm-39-03-0603"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Stevens</surname><given-names>MV</given-names></name><name><surname>Kohr</surname><given-names>M</given-names></name><name><surname>Steenbergen</surname><given-names>C</given-names></name><name><surname>Sack</surname><given-names>MN</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name></person-group><article-title>Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore</article-title><source>J Biol Chem</source><volume>286</volume><fpage>40184</fpage><lpage>40192</lpage><year>2011</year><pub-id pub-id-type="doi">10.1074/jbc.M111.243469</pub-id><pub-id pub-id-type="pmid">21930693</pub-id><pub-id pub-id-type="pmcid">3220546</pub-id></element-citation></ref>
<ref id="b37-ijmm-39-03-0603"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Gaizo Moore</surname><given-names>V</given-names></name><name><surname>Letai</surname><given-names>A</given-names></name></person-group><article-title>BH 3 profiling - measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions</article-title><source>Cancer Lett</source><volume>332</volume><fpage>202</fpage><lpage>205</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.canlet.2011.12.021</pub-id></element-citation></ref>
<ref id="b38-ijmm-39-03-0603"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>DW</given-names></name><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Wang</surname><given-names>YD</given-names></name><name><surname>Li</surname><given-names>GR</given-names></name></person-group><article-title>Atorvastatin protects endothelial colony forming cells against H<sub>2</sub>O<sub>2</sub> induced oxidative damage by regulating the expression of Annexin A2</article-title><source>Mol Med Rep</source><volume>12</volume><fpage>7941</fpage><lpage>7948</lpage><year>2015</year><pub-id pub-id-type="pmid">26497173</pub-id><pub-id pub-id-type="pmcid">4758293</pub-id></element-citation></ref>
<ref id="b39-ijmm-39-03-0603"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Huo</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Fei</surname><given-names>Z</given-names></name></person-group><article-title>Iduna protects HT22 cells from hydrogen peroxide-induced oxidative stress through interfering poly(ADP-ribose) polymerase-1-induced cell death (parthanatos)</article-title><source>Cell Signal</source><volume>25</volume><fpage>1018</fpage><lpage>1026</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.01.006</pub-id><pub-id pub-id-type="pmid">23333241</pub-id></element-citation></ref>
<ref id="b40-ijmm-39-03-0603"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuzil</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>XF</given-names></name><name><surname>Dong</surname><given-names>LF</given-names></name><name><surname>Low</surname><given-names>P</given-names></name><name><surname>Ralph</surname><given-names>SJ</given-names></name></person-group><article-title>Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins</article-title><source>FEBS Lett</source><volume>580</volume><fpage>5125</fpage><lpage>5129</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.febslet.2006.05.072</pub-id><pub-id pub-id-type="pmid">16979626</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijmm-39-03-0603" position="float">
<label>Figure 1</label>
<caption>
<p>Chemical structure of morroniside.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g00.tif"/></fig>
<fig id="f2-ijmm-39-03-0603" position="float">
<label>Figure 2</label>
<caption>
<p>(A) Effects of H<sub>2</sub>O<sub>2</sub> on SK-N-SH cell viability. Cell viability was reduced in a dose- and time-dependent manner by treatment with H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M for 24). (B) Effects of morroniside on SK-N-SH cell viability. Morroniside treatment did not affect cell viability at concentrations of 1, 10 and 100 <italic>&#x000B5;</italic>M. (C) Effects of morroniside on H<sub>2</sub>O<sub>2</sub>-induced SK-N-SH cell death. Pretreatment with morroniside (1&#x02013;100 <italic>&#x000B5;</italic>M) for 24 h restored viability in cells exposed to H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) in a dose-dependent manner. (D) Morroniside inhibits morphological changes resulting from H<sub>2</sub>O<sub>2</sub> treatment. Scale bar, 20 <italic>&#x000B5;</italic>M. (E) Morroniside suppresses H<sub>2</sub>O<sub>2</sub>-induced lactate dehydrogenase (LDH) release in SK-N-SH cells. Cells were pretreated with indicated concentrations of morroniside (1&#x02013;100 <italic>&#x000B5;</italic>M) for 24 h following treatment with 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> or no treatment for 24 h. LDH activity in the medium was measured. Data represent mean &#x000B1; SD (n=3). <sup>#</sup>P&lt;0.05, <sup>##</sup>P&lt;0.01 and <sup>###</sup>P&lt;0.001 vs. control group; <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001 vs. H<sub>2</sub>O<sub>2</sub>-treated group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g01.tif"/></fig>
<fig id="f3-ijmm-39-03-0603" position="float">
<label>Figure 3</label>
<caption>
<p>Morroniside blocks H<sub>2</sub>O<sub>2</sub>-induced apoptosis of SK-N-SH cells. Apoptotic nuclei were visualized by Hoechst 33342 staining. (A) Untreated cells with normal nuclei. (B) Cells exposed to 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> with condensed nuclei. (C&#x02013;E) Cells pretreated with morroniside at concentrations of (C) 1 <italic>&#x000B5;</italic>M, (D) 10 <italic>&#x000B5;</italic>M and (E) 100 <italic>&#x000B5;</italic>M for 24 h showed reduced sensitivity to the effects of H<sub>2</sub>O<sub>2</sub>, as evidenced by fewer cells with condensed nuclei. Scale bar, 20 <italic>&#x000B5;</italic>M. (G&#x02013;K) Annexin V/propidium iodide (PI) double-staining was used to confirm apoptosis in SK-N-SH cells. Few cells positive for Annexin V/PI staining were detected in the control group (G), while H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) treatment increased the percentage of Annexin V<sup>+</sup>/PI<sup>+</sup> cells (H). Preincubation with (I) 1 <italic>&#x000B5;</italic>M, (J) 10 <italic>&#x000B5;</italic>M and (K) 100 <italic>&#x000B5;</italic>M morroniside for 24 h inhibited H<sub>2</sub>O<sub>2</sub>-induced apoptosis. Quantitative analyses are shown in panels (F and L). Data represent mean &#x000B1; SD of three independent experiments. <sup>###</sup>P&lt;0.001 vs. control group; <sup>&#x0002A;</sup>P&lt;0.01, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001 vs. injury group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g02.tif"/></fig>
<fig id="f4-ijmm-39-03-0603" position="float">
<label>Figure 4</label>
<caption>
<p>Morroniside attenuates H<sub>2</sub>O<sub>2</sub>-induced accumulation of intracellular reactive oxygen species (ROS) in SK-N-SH cells. Cells were pretreated with (D&#x02013;F) 10 <italic>&#x000B5;</italic>M morroniside for 24 h followed by (B and E) 200 <italic>&#x000B5;</italic>M or (C and F) 400 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h. Untreated control cells are shown in (A). ROS levels were increased in a dose-dependent manner by treatment with (B) 200 <italic>&#x000B5;</italic>M and (C) 400 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub>. The increase was abolished by pretreatment with 10 <italic>&#x000B5;</italic>M morroniside (E and F). Intracellular superoxide anion levels were measured by dihydroethidium staining. Compared to the control (H), H<sub>2</sub>O<sub>2</sub> (200 <italic>&#x000B5;</italic>M) increased superoxide anion production (I), an effect that was reversed by pretreatment with (J) 1 <italic>&#x000B5;</italic>M, (K) 10 <italic>&#x000B5;</italic>M and (L) 100 <italic>&#x000B5;</italic>M morroniside. Quantitative analyses are shown (G and M). Data represent mean &#x000B1; SD of three independent experiments. <sup>##</sup>P&lt;0.01 and <sup>###</sup>P&lt;0.001 vs. control group; <sup>&#x0002A;</sup>P&lt;0.01, <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001 vs. injury group. Scale bars: (F) 50 <italic>&#x000B5;</italic>M and (L) 20 <italic>&#x000B5;</italic>M.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g03.tif"/></fig>
<fig id="f5-ijmm-39-03-0603" position="float">
<label>Figure 5</label>
<caption>
<p>Effect of morroniside on H<sub>2</sub>O<sub>2</sub>-induced lipid oxidation. Cells were pretreated with indicated concentrations of morroniside for 24 h followed by 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub> for 24 h. Data represent mean &#x000B1; SD of three independent experiments. <sup>###</sup>P&lt;0.001 vs. control group; <sup>&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. injury group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g04.tif"/></fig>
<fig id="f6-ijmm-39-03-0603" position="float">
<label>Figure 6</label>
<caption>
<p>Morroniside blocks the H<sub>2</sub>O<sub>2</sub>-induced decrease in superoxide dismutase (SOD) level in SK-N-SH cells. Cells were pre-incubated with 1, 10 or 100 <italic>&#x000B5;</italic>M morroniside for 24 h followed by H<sub>2</sub>O<sub>2</sub> for 24 h. Data represent mean &#x000B1; SD of three independent experiments. <sup>###</sup>P&lt;0.001 vs. control group; <sup>&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. injury group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g05.tif"/></fig>
<fig id="f7-ijmm-39-03-0603" position="float">
<label>Figure 7</label>
<caption>
<p>Inhibition of H<sub>2</sub>O<sub>2</sub>-induced reduction in mitochondrial membrane potential (MMP) by morroniside. (A and B) Cells were pretreated with the indicated concentrations of morroniside followed by 200 <italic>&#x000B5;</italic>M H<sub>2</sub>O<sub>2</sub>. The decrease in MMP was quantified with JC-1 staining and fluorescence microscopy. Scale bar, 20 <italic>&#x000B5;</italic>M.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g06.tif"/></fig>
<fig id="f8-ijmm-39-03-0603" position="float">
<label>Figure 8</label>
<caption>
<p>Effect of morroniside on caspase-3 activity. Cells were pretreated with indicated concentrations of morroniside for 24 h followed by H<sub>2</sub>O<sub>2</sub> for 24 h. Data represent mean &#x000B1; SD of four independent experiments. <sup>##</sup>P&lt;0.01 vs. control group; <sup>&#x0002A;</sup>P&lt;0.01 and <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01 vs. injury group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g07.tif"/></fig>
<fig id="f9-ijmm-39-03-0603" position="float">
<label>Figure 9</label>
<caption>
<p>Effect of morroniside on the expression of apoptosis-related proteins. Cells were pretreated with the indicated concentrations of morroniside for 24 h followed by H<sub>2</sub>O<sub>2</sub> for 24 h. Bcl-2 and Bax expression was evaluated by (A&#x02013;C) RT-PCR and (D&#x02013;F) western blotting. Values represent mean &#x000B1; SD of three independent experiments. <sup>##</sup>P&lt;0.01 and <sup>###</sup>P&lt;0.001 vs. the control group; <sup>&#x0002A;&#x0002A;</sup>P&lt;0.01and <sup>&#x0002A;&#x0002A;&#x0002A;</sup>P&lt;0.001 vs. the injury group.</p></caption>
<graphic xlink:href="IJMM-39-03-0603-g08.tif"/></fig>
<table-wrap id="tI-ijmm-39-03-0603" position="float">
<label>Table I</label>
<caption>
<p>Sequences of the primers and PCR product sizes used in RT-PCR.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="middle" align="left">Gene</th>
<th valign="middle" align="center">Primer</th>
<th valign="middle" align="center">Sequence</th>
<th valign="middle" align="center">Size (bp)</th></tr></thead>
<tbody>
<tr>
<td rowspan="2" valign="top" align="left">GAPDH</td>
<td valign="top" align="left">Sense</td>
<td valign="top" align="left">5&#x02032;-AGAAGGCTGGGGCTCATTTG-3&#x02032;</td>
<td valign="top" align="center">258</td></tr>
<tr>
<td valign="top" align="left">Antisense</td>
<td valign="top" align="left">5&#x02032;-AGGGGCCATCCACAGTCTTC-3&#x02032;</td>
<td valign="top" align="center"/></tr>
<tr>
<td rowspan="2" valign="top" align="left">Bax</td>
<td valign="top" align="left">Sense</td>
<td valign="top" align="left">5&#x02032;-CCAAGGTGCCGGAACTGA-3&#x02032;</td>
<td valign="top" align="center">57</td></tr>
<tr>
<td valign="top" align="left">Antisense</td>
<td valign="top" align="left">5&#x02032;-CCCGGAGGAAGTCCAATGT-3&#x02032;</td>
<td valign="top" align="center"/></tr>
<tr>
<td rowspan="2" valign="top" align="left">Bcl-2</td>
<td valign="top" align="left">Sense</td>
<td valign="top" align="left">5&#x02032;-CATGTGTGTGGAGAGCGTCAAC-3&#x02032;</td>
<td valign="top" align="center">187</td></tr>
<tr>
<td valign="top" align="left">Antisense</td>
<td valign="top" align="left">5&#x02032;-CTTCAGAGACAGCCAGGAGAAATC-3&#x02032;</td>
<td valign="top" align="center"/></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ijmm-39-03-0603">
<p>GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Bax, Bcl-2-associated X protein; Bcl-2, B cell lymphoma-2.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
